Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

31,216 stories, page 8 of 521

Advanced search

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07661641: A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07619547: Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07600892: Pain-at-Work Toolkit (Definitive Trial)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07599176: Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07540221: A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07468851: A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07468071: Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07416604: A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07416552: A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07412002: Quality of End-of-Life Care for Children With Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07361562: A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07314957: Impact of Lifestyle on Health Maintenance: A Randomized Controlled Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07252297: The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07144111: A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07111065: FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07109336: Development and Prospective Validation of a Heterogeneous Treatment Effect-Based Decision Model for Transarterial Chemoembolization Combined With or Without Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT07066813: Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT06968988: Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT06948097: Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT06717334: A Study of Lung Cancer Screening in People With Unexplained Weight Loss

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT06526338: Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT06414408: Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT06364410: Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT06333392: Total Underwater Colonoscopy (TUC) for Improved Colorectal Cancer Screening: A Randomized Controlled Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT06295679: A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT06274749: Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT06126224: A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT06112613: Mobile Health for Adherence in Breast Cancer Patients

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT06062498: Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT05990946: Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT05933174: Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT05906004: Post-Market Clinical Follow-up (PMCF) Study of the Pitch-Patch for the Augmentation or Reinforcement of the Rotator Cuff

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT05761782: Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT05739383: A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT05688605: A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT05198830: Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT04815356: Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT04230356: Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT02559778: Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT01972919: MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Sep 4Researchclinicaltrials.gov

NCT00001778: Evaluation of Patients With HAM/TSP

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🌍Sep 4discoverynews.google.com

GC Green Cross Receives IND Approval for Phase 2/3 Clinical Trial of High-Immunogenicity Influenza Vaccine

아시아경제Original source

🌍Sep 4discoverynews.google.com

Biotech company Diatherix plans layoffs

The Business JournalsOriginal source

🌍Sep 4discoverynews.google.com

Up to 20% of children with Dravet syndrome die before adulthood. A long-term study of an experimental drug showed fewer severe seizures.

Stock TitanOriginal source

🌍Sep 4discoverynews.google.com

BIG Executive Summit: Lasting Impacts on Biotech Adoption

BioProcess InternationalOriginal source

🌍Sep 4discoverynews.google.com

Heartland BioWorks tackles Indiana’s biotech labor shortage

BioProcess InternationalOriginal source

🌍Sep 4discoverynews.google.com

South Korean Biotech Licensing Deals Top ₩21 Trillion, but Stock Prices Lag — Recovery Hinges on Market Liquidity

finance.biggo.comOriginal source

🌍Sep 4discoverynews.google.com

FDA Approves First Drug to Treat Alexander Disease

finchannelOriginal source

🌍Sep 4discoverynews.google.com

Polyrizon raises $4M as intranasal hydrogel biotech taps single investor

app.dealroom.coOriginal source

🌍Sep 4discoverynews.google.com

Viral infections biotech ENA Respiratory inhales $3 million from government fund

Startup DailyOriginal source

🌍Sep 4discoverynews.google.com

BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?

The Motley FoolOriginal source

🌍Sep 4discoverynews.google.com

EXCLUSIVE: AI, Genomics Could Fuel Biotech ETF Re-Rating as Health Care Trades at Discount, Says Expert

BenzingaOriginal source

🌍Sep 4discoverynews.google.com

GLP-1 Drugs Tied to Higher Male Pattern Hair Loss Risk

labroots.comOriginal source

🌍Sep 4discoverynews.google.com

Nuvectis Pharma draws top biotech funds after $115M raise

app.dealroom.coOriginal source

🌍Sep 4discoverynews.google.com

Yuce Biotech raises $7.4M Series B for single-molecule immunodiagnostics

DealroomOriginal source

🌍Sep 4discoverynews.google.com

Frost & Sullivan Released the 2026 Blue Book on the Development of Hong Kong Stock Exchange 18A Biotech Sector

wkow.comOriginal source

🌍Sep 4discoverynews.google.com

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Cut to $28.00 by Analysts at Jefferies Financial Group

MarketBeatOriginal source

🌍Sep 4discoverynews.google.com

FDA Approves Zilganersen Injection, First Drug for Alexander Disease

Pharmacy TimesOriginal source

🌍Sep 4discoverynews.google.com

Eascra Biotech expands Worcester presence following $8M NASA award

Worcester Business JournalOriginal source

🌍Sep 4discoverynews.google.com

Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder

STATOriginal source